National University of Singapore

The National University of Singapore (NUS) is a prominent institution known for its research and academic excellence. NUS is currently engaged in a significant collaboration with MitoQ, focusing on clinical trials. These trials are centered around assessing the effects and benefits of mitoquinol, particularly targeting Asian consumers.

Collaborative Efforts with MitoQ

This collaboration marks a critical step in understanding how mitoquinol can benefit consumers in Asia. By undertaking these clinical trials, NUS aims to contribute to the broader scientific community's understanding of mitoquinol's potential health impacts.

Modified: 2026/07/21

---